English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, April 20, 2022
Actual net profit exceeds FY2020's level, China Biotech Services' (08037) new growth drivers expected to erupt consecutively
Tuesday, August 10, 2021
AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China
Monday, June 28, 2021
China Biotech (8037.HK): Anticipating promising results from cell therapy and from precision diagnostics
Thursday, June 24, 2021
中國生物科技服務(8037.HK):細胞治療和精准檢測業務雙輪驅動 股東增持彰顯發展信心
Friday, January 29, 2021
上海隆耀首席科学家杨选明教授发表使用OX40优化CAR-T细胞功能相关学术研究
上海隆耀首席科學家楊選明教授發表使用OX40優化CAR-T細胞功能相關學術研究
Shanghai Longyao Chief Scientist Professor Xuanming Yang published a research article on optimizing CAR-T cells function with independently expressed full-length OX40
Thursday, January 28, 2021
中国生物科技服务LY007细胞注射液获临床试验批准通知书
中國生物科技服務LY007細胞注射液獲臨床試驗批准通知書
China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575